Lifecore Biomedical, Inc. LFCR Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NotesAndLoansReceivableNetCurrent.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s accounts receivable?
- Lifecore Biomedical, Inc. (LFCR) reported accounts receivable of $0 in Q3 2025.
- How has Lifecore Biomedical, Inc.'s accounts receivable changed year-over-year?
- Lifecore Biomedical, Inc.'s accounts receivable decreased by 100.0% year-over-year, from $30.86M to $0.
- What is the long-term trend for Lifecore Biomedical, Inc.'s accounts receivable?
- Over 4 years (2021 to 2025), Lifecore Biomedical, Inc.'s accounts receivable has grown at a -29.1% compound annual growth rate (CAGR), from $31.59M to $8M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.